Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on World Politics Report.
Press releases published on July 31, 2025

Corbion delivers Sales of € 645.6 million and an improvement of EBITDA margins of +300 bps for first-half 2025; full-year outlook maintained
Corbion, the Amsterdam-listed sustainable ingredients company that champions preservation through application of science, today publishes its half-year 2025 results ending 30 June 2025. - Organic sales growth: +2.9% (Q2: -1.6%) - Volume/mix: …

Pharming Group reports second quarter and first half 2025 financial results and provides business update
Second quarter 2025 total revenues increased by 26% to US$93.2 million, compared to the second quarter 2024, driven by strong RUCONEST® and Joenja® revenue growth RUCONEST® second quarter revenue increased by 28% to US$80.4 million, compared to the second …

argenx Reports Half Year 2025 Financial Results and Provides Second Quarter Business Update
$949 million in second quarter global product net sales VYVGART SC launch in CIDP progresses with more than 2,500 patients on treatment globally ARGX-119 to advance to registrational study in CMS following positive proof of concept data; three additional …

ArcelorMittal S.A.: ArcelorMittal reports second quarter 2025
Luxembourg, July 31, 2025 - ArcelorMittal (referred to as “ArcelorMittal” or the “Company” or the "Group") (MT (New York, Amsterdam, Paris, Luxembourg), MTS (Madrid)), the world’s leading integrated steel and mining company, today announced results1 for …

Ipsen delivers strong results in the first half of 2025 and upgrades its full-year guidance
H1 total sales growth of 11.4% at CER1, or 9.7% as reported, driven by the three therapeutic areas: 95.7% in Rare Disease, 9.7% in Neuroscience, and 6.4% in Oncology H1 core operating income of €656m, growing by 21.9% as reported, with a core operating …

Ipsen publie de solides résultats au premier semestre 2025 et relève ses objectifs financiers annuels
Croissance des ventes totales du Groupe de 11,4% à taux de change constant1 ou 9,7% en données publiées, tirée par les trois aires thérapeutiques : 95,7% dans les Maladies Rares, 9,7% en Neurosciences et 6,4% en Oncologie Résultat opérationnel des …

ING posts 2Q2025 net result of €1,675 million, with strong growth in lending volumes and fee income
CEO statement “During the second quarter of 2025, we have continued to successfully execute our strategy, which we set out one year ago, by accelerating growth, increasing impact and delivering value,” said Steven van Rijswijk, CEO of ING. “The quarter …